Home / Biotechnology / Drug of Abuse Testing / Screening Market By Test Type (Urine Drug Tests, Oral Fluid Drug Tests, Hair Drug Tests, Blood Drug Tests, Other Drug Tests), Location (On-site Screening, Laboratory-based Screening) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Drug of Abuse Testing / Screening Market By Test Type (Urine Drug Tests, Oral Fluid Drug Tests, Hair Drug Tests, Blood Drug Tests, Other Drug Tests), Location (On-site Screening, Laboratory-based Screening) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: May 2016 | Report Code: 57815-05-16

This report on drug abuse testing/screening market studies various test and location types. For decades, drug of abuse test samples were transferred to laboratories with results returned days or even weeks later. More recently, point-of-collection (POC) testing became omnipresent, permitting detection of some drugs and/or their metabolites within minutes of collection. According to market experts, leading countries from North America and Europe are applying drug of abuse tests at several organizational levels such as on the spot drug/alcohol screening, post incident drug/alcohol screening, pre-employment screening, and abstinence monitoring. Government regulations and policies in these countries are assisting the growth of drug abuse testing market mainly through practice of drug testing at workplace.

For the purpose of this study, the global drug abuse testing/screening market on the basis of test type is segmented into urine drug tests, oral fluid drug tests, hair drug tests, blood drug tests, and other drug tests. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of location type drug abuse testing/screening market is segmented as on-site screening and laboratory-based screening. Laboratory based tests possess skilled and trained personnel for providing detailed analysis and onsite drugs of abuse testing provide immediate results. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The drug abuse testing/screening market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The major key players profiled in the drug abuse testing/screening market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Abbott Laboratories, Psychemedics Corporation, Sonic Healthcare, Bio-Rad Laboratories, Alere,Inc., F. Hoffman-La Roche, Quest Diagnostics, and Randox Laboratories.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Drug Abuse Testing/Screening Market, by Test Type, 2015 (USD Mn)
2.2 Drug Abuse Testing/Screening Market Share, by Location Type, 2015 & 2022 (Value %)
2.3 Drug Abuse Testing/Screening Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Drug Abuse Testing/Screening Market: Market Dynamics and Outlook
3.1 Drug Abuse Testing/Screening : Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Drug Abuse Testing/Screening Manufacturers, 2015 (%)

Chapter 4 Global Drug Abuse Testing/Screening Market Analysis, by Test Type
4.1 Preface
4.2 Urine Drug Tests
4.3 Oral Fluid Drug Tests
4.4 Hair Drug Tests
4.5 Blood Drug Tests
4.6 Other Drug Tests

Chapter 5 Global Drug Abuse Testing/Screening Market Analysis, by Location Type
5.1 Preface
5.2 On-site Screening
5.3 Laboratory-based Screening

Chapter 6 Global Drug Abuse Testing/Screening Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (LATAM)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of LATAM
6.6 Middle East and Africa (MEA)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and budget allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Thermo Fisher Scientific
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Alere, Inc.
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 LabCorp (Laboratory Corporation of America)
8.4.1 Business Description
8.4.2 Financial Health and budget allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Psychemedics Corporation
8.5.1 Business Description
8.5.2 Financial Health and budget allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Sonic Healthcare
8.6.1 Business Description
8.6.2 Financial Health and budget allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Bio-Rad Laboratories
8.7.1 Business Description
8.7.2 Financial Health and budget allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Compsetitors
8.7.5 News Coverage
8.8 Quest Diagnostics
8.8.1 Business Description
8.8.2 Financial Health and budget allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Randox Laboratories
8.9.1 Business Description
8.9.2 Financial Health and budget allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 F. Hoffman-La Roche
8.10.1 Business Description
8.10.2 Financial Health and budget allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage

List of Figures

FIG. 1 Drug Abuse Testing/Screening : Market Segmentation
FIG. 2 Drug Abuse Testing/Screening Market, by Test Type, 2015 (USD Mn)
FIG. 3 Drug Abuse Testing/Screening Market Share, by Location Type, 2015 & 2022 (Value %)
FIG. 4 Drug Abuse Testing/Screening Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Drug Abuse Testing/Screening Market, 2015
FIG. 6 Key Players Market Share Analysis for Drug Abuse Testing/Screening, 2015(%)
FIG. 7 Global Urine Drug Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Oral Fluid Drug Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Hair Drug Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Blood Drug Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global Other Drug Tests Market Revenue, 2013 – 2022 (USD Mn)
FIG. 12 Global On-site Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Global Laboratory-Based Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 14 U.S. Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Canada Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 U.K. Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 17 Germany Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 18 Rest of Europe Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022
(USD Mn)
FIG. 19 China Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 20 Japan Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 21 Rest of Asia-Pacific Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD
Mn)
FIG. 22 Brazil Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 23 Mexico Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)
FIG. 24 Rest of LATAM Drug of Abuse Testing/Screening Market Revenue, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Drug Abuse Testing/Screening Market Revenue, by Test Type, 2013 – 2022 (USD Mn)
TABLE 2 Global Drug Abuse Testing/Screening Market Revenue, by Location Type, 2013 – 2022 (USD Mn)
TABLE 3 Global Drug Abuse Testing/Screening Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America Drug Abuse Testing/Screening Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe Drug Abuse Testing/Screening Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia - Pacific Drug Abuse Testing/Screening Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Latin America Drug Abuse Testing/Screening Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 8 Middle East and Africa Drug Abuse Testing/Screening Market Revenue, by Region, 2013 – 2022 (USD Mn)

Location Type Segmentation Investigation

Based on the type of location, the global drug of abuse testing/screening market is segmented as follows:

  • On-site Screening
  • Laboratory-based Screening

In year 2015, the laboratory-based screening segment accounted for the largest market share in the global drug of abusing testing market. One of the key requirements of laboratory-based drug of abuse test location is trained and skilled personnel to provide an accurate result along with in-depth analysis. In laboratory-based screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other advanced techniques to provide accurate results. On the other hand, on-site drug screening test provides accurate results and it is generally preferred for those who take the drug test at home, workplace and educational institutions.

Drug of Abuse Testing / Screening Market 

Test Type Segmentation Analysis

Based on the type of test, the drug of abuse testing / screening market is segmented into:

  • Urine Drug Tests
  • Oral Fluid Drug Tests
  • Hair Drug Tests
  • Blood Drug Tests
  • Other Drug Tests

In base year 2015, the urine and oral fluid drug tests collectively attribute the largest share in the market in terms of revenue (USD). According to Quest Diagnostics, Inc., urine drug testing detects recent drug use and is the only testing method approved for federally-mandated testing. End-users seemed to rely on laboratory-based urine testing for its cost-effectiveness and capacity to screen for a wide variety of drug substances. Urine testing was observed as the most common screening method and detects recent use, typically in the previous one to three days. Its application is also apt for all testing reasons – from pre-employment to random to post-accident – and can be performed for a wide range of illicit and prescription drugs. Market experts also suggest that despite market entry of novel solutions and products, lab based urine drug testing is still the gold standard in employee drug testing.

Drug of Abuse Testing / Screening Market

 


 

  

For the purpose of this study, the global drug of abuse testing or screening market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Drug of Abuse Testing / Screening Market

In base year 2015, North America accounted for the largest share in the global drug of abuse testing/screening market, followed by Asia-Pacific, Europe, LATAM and MEA. The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2022. The key factors such as enormous production of illicit drugs, their illegal trade, and increasing consumption have encouraged companies in North America and Europe to conduct drug screening tests such as pre-employment screening, abstinence monitoring, post-incident drug/alcohol screening, and random drug/alcohol screening. The other factors such as government regulations supporting the screening of drug abuse at workplaces have also assisted the growth of drugs of abuse testing market throughout the forecast period.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients